1 - 25 of
49
results
for author:"Ho I."
in Literature Citations
| Induction of neoplastic transformation by ectopic expression of human aldo-keto reductase 1C isoforms in NIH3T3 cells. Chien C.W., Ho I.C., Lee T.C. Carcinogenesis 30:1813-1820(2009) · Mapped (2) |
| Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. Pot C., Jin H., Awasthi A., Liu S.M., Lai C.Y., Madan R., Sharpe A.H., Karp C.L., Miaw S.C., Ho I.C. et al. J. Immunol. 183:797-801(2009) · Mapped (14) |
| Matrix metalloproteinase 1 is necessary for the migration of human bone marrow-derived mesenchymal stem cells toward human glioma. Ho I.A., Chan K.Y., Ng W.H., Guo C.M., Hui K.M., Cheang P., Lam P.Y. Stem Cells 27:1366-1375(2009) · Mapped (10) |
| CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis. Pei X.H., Bai F., Smith M.D., Usary J., Fan C., Pai S.Y., Ho I.C., Perou C.M., Xiong Y. Cancer Cell 15:389-401(2009) · Mapped (10) |
| The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Bauquet A.T., Jin H., Paterson A.M., Mitsdoerffer M., Ho I.C., Sharpe A.H., Kuchroo V.K. Nat. Immunol. 10:167-175(2009) · Mapped (7) |
| IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., Mitsdoerffer M., Strom T.B., Elyaman W., Ho I.C. et al. Nat. Immunol. 9:1347-1355(2008) · Mapped (22) |
| IL-2 receptor beta-chain signaling controls immunosuppressive CD4+ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo. Doganci A., Karwot R., Maxeiner J.H., Scholtes P., Schmitt E., Neurath M.F., Lehr H.A., Ho I.C., Finotto S. J. Immunol. 181:1917-1926(2008) · Mapped (10) |
| Role of Ets-1 phosphorylation in the effector function of Th cells. Grenningloh R., Miaw S.C., Moisan J., Graves B.J., Ho I.C. Eur. J. Immunol. 38:1700-1705(2008) · Mapped (8) |
| GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Kouros-Mehr H., Bechis S.K., Slorach E.M., Littlepage L.E., Egeblad M., Ewald A.J., Pai S.Y., Ho I.C., Werb Z. Cancer Cell 13:141-152(2008) · Mapped (5) |
| Distinct structural requirements of GATA-3 for the regulation of thymocyte and Th2 cell differentiation. Pai S.Y., Kang B.Y., Sabadini A.M., Parisini E., Truitt M.L., Ho I.C. J. Immunol. 180:1050-1059(2008) · Mapped (5) |
| Ets-1 is a negative regulator of Th17 differentiation. Moisan J., Grenningloh R., Bettelli E., Oukka M., Ho I.C. J. Exp. Med. 204:2825-2835(2007) · Mapped (21) |
| c-Maf interacts with c-Myb to down-regulate Bcl-2 expression and increase apoptosis in peripheral CD4 cells. Peng S., Lalani S., Leavenworth J.W., Ho I.-C., Pauza M.E. Eur. J. Immunol. 37:2868-2880(2007) · UniProtKB (2) · Mapped (11) |
| Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation. Ho I.S., Hannan F., Guo H.F., Hakker I., Zhong Y. J. Neurosci. 27:6852-6857(2007) · Mapped (16) |
| Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. de Guzman Strong C., Wertz P.W., Wang C., Yang F., Meltzer P.S., Andl T., Millar S.E., Ho I.C., Pai S.Y., Segre J.A. J. Cell Biol. 175:661-670(2006) · Mapped (28) |
| GATA-3 regulates the development and function of invariant NKT cells. Kim P.J., Pai S.Y., Brigl M., Besra G.S., Gumperz J., Ho I.C. J. Immunol. 177:6650-6659(2006) · Mapped (12) |
| Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. Lee T.C., Ho I.C., Lu W.J., Huang J.D. J. Biol. Chem. 281:18401-18407(2006) · Mapped (7) |
| Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation. Kim D.C., Hsu F.I., Barrett N.A., Friend D.S., Grenningloh R., Ho I.C., Al-Garawi A., Lora J.M., Lam B.K., Austen K.F. et al. J. Immunol. 176:4440-4448(2006) · Mapped (2) |
| Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras. Hannan F., Ho I., Tong J.J., Zhu Y., Nurnberg P., Zhong Y. Hum. Mol. Genet. 15:1087-1098(2006) · Mapped (3) |
| Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. Zhan Y., Brown C., Maynard E., Anshelevich A., Ni W., Ho I.C., Oettgen P. J. Clin. Invest. 115:2508-2516(2005) · Mapped (8) |
| Butorphanol dependence increases hippocampal kappa-opioid receptor gene expression. Tanaka S., Fan L.W., Tien L.T., Park Y., Liu-Chen L.Y., Rockhold R.W., Ho I.K. J. Neurosci. Res. 82:255-263(2005) · Mapped (1) |
| A lack of mu-opioid receptors modulates the expressions of neuropeptide Y and substance P mRNA. Yoo J.H., Cho J.H., Lee S.Y., Loh H.H., Ho I.K., Jang C.G. Neurosci. Lett. 384:29-32(2005) · Mapped (44) |
| Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. Grenningloh R., Kang B.Y., Ho I.C. J. Exp. Med. 201:615-626(2005) · Mapped (11) |
| ROG negatively regulates T-cell activation but is dispensable for Th-cell differentiation. Kang B.Y., Miaw S.C., Ho I.C. Mol. Cell. Biol. 25:554-562(2005) · Mapped (2) |
| Changes in acetylcholinesterase activity and muscarinic receptor bindings in mu-opioid receptor knockout mice. Tien L.T., Fan L.W., Sogawa C., Ma T., Loh H.H., Ho I.K. Brain Res. Mol. Brain Res. 126:38-44(2004) · Mapped (49) |
| The DNA sequence and biology of human chromosome 19. Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M. et al. Nature 428:529-535(2004) · UniProtKB (1,180) |
